LORENZI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 934
AS - Asia 796
EU - Europa 308
SA - Sud America 114
AF - Africa 100
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.265
Nazione #
US - Stati Uniti d'America 880
SG - Singapore 237
VN - Vietnam 152
CN - Cina 131
HK - Hong Kong 96
BR - Brasile 73
IT - Italia 60
DE - Germania 31
GB - Regno Unito 29
IN - India 27
FR - Francia 24
SE - Svezia 23
FI - Finlandia 18
TR - Turchia 18
PL - Polonia 17
NL - Olanda 16
BD - Bangladesh 13
CA - Canada 13
IQ - Iraq 13
RU - Federazione Russa 12
SA - Arabia Saudita 9
AR - Argentina 8
JO - Giordania 8
PY - Paraguay 8
AT - Austria 7
BJ - Benin 7
CO - Colombia 7
GE - Georgia 7
KR - Corea 7
ZA - Sudafrica 7
IE - Irlanda 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AO - Angola 5
CR - Costa Rica 5
ES - Italia 5
GN - Guinea 5
ID - Indonesia 5
JP - Giappone 5
LA - Repubblica Popolare Democratica del Laos 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CD - Congo 4
CM - Camerun 4
DK - Danimarca 4
IL - Israele 4
LV - Lettonia 4
MR - Mauritania 4
PA - Panama 4
PK - Pakistan 4
PR - Porto Rico 4
RW - Ruanda 4
SD - Sudan 4
TW - Taiwan 4
AD - Andorra 3
AL - Albania 3
BZ - Belize 3
CH - Svizzera 3
CL - Cile 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DJ - Gibuti 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
KH - Cambogia 3
LY - Libia 3
ME - Montenegro 3
MG - Madagascar 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
PF - Polinesia Francese 3
PT - Portogallo 3
RE - Reunion 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
UA - Ucraina 3
AU - Australia 2
BF - Burkina Faso 2
BO - Bolivia 2
BW - Botswana 2
CU - Cuba 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
GF - Guiana Francese 2
GH - Ghana 2
HR - Croazia 2
HT - Haiti 2
Totale 2.200
Città #
Singapore 145
Ashburn 138
San Jose 86
Hong Kong 78
Fairfield 75
Chandler 61
Ho Chi Minh City 44
Hanoi 40
Woodbridge 38
Santa Clara 35
Houston 33
Los Angeles 31
Cambridge 30
Beijing 28
Seattle 21
New York 16
Council Bluffs 15
Padova 15
Wilmington 14
Helsinki 13
San Diego 13
London 12
São Paulo 11
Boardman 10
Da Nang 10
Ann Arbor 9
Haiphong 9
Amman 8
Amsterdam 8
Buffalo 8
Bytom 8
Chicago 8
Hefei 8
Istanbul 8
Lauterbourg 8
Medford 8
Milan 8
Montreal 8
Princeton 8
Cotonou 7
Dallas 7
Munich 7
Warsaw 7
Des Moines 6
Orem 6
Chennai 5
Conakry 5
Frankfurt am Main 5
Luanda 5
Nuremberg 5
Seoul 5
Tashkent 5
Ankara 4
Brooklyn 4
Ciudad del Este 4
Columbus 4
Guangzhou 4
Hsinchu County 4
Kigali 4
Kowloon Bay 4
Nouakchott 4
Pune 4
Riga 4
Riyadh 4
Salt Lake City 4
Tbilisi 4
Tokyo 4
Vientiane 4
Washington 4
Antananarivo 3
Asunción 3
Belo Horizonte 3
Boston 3
Dammam 3
Djibouti 3
Dubai 3
Dublin 3
Falkenstein 3
Johannesburg 3
Kinshasa 3
Ludhiana 3
Marseille 3
Nha Trang 3
Panama City 3
Podgorica 3
Roxbury 3
San José 3
Vienna 3
Accra 2
Andorra la Vella 2
Atlanta 2
Baghdad 2
Belgrade 2
Belluno 2
Benghazi 2
Biên Hòa 2
Bologna 2
Brasília 2
Bratislava 2
Buenos Aires 2
Totale 1.350
Nome #
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 281
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 259
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 257
Extraskeletal Myxoid Chondrosarcoma: clinical and molecular characteristics and outcomes of patients treated at two Institutions 245
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 245
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 243
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 228
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 187
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab 184
Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World 150
Totale 2.279
Categoria #
all - tutte 6.984
article - articoli 6.984
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 1 13
2021/2022195 3 16 34 11 14 32 25 7 9 8 8 28
2022/2023139 17 21 6 19 10 13 2 14 29 3 5 0
2023/2024125 13 13 17 11 10 29 11 4 3 5 5 4
2024/2025328 0 22 15 18 47 16 7 35 31 8 50 79
2025/20261.354 79 90 162 193 116 71 275 93 162 71 42 0
Totale 2.279